NASH and Systemic Complications

Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH). NASH is a chronic inflammatory condition of the liver that can further progress...

詳細記述

保存先:

書誌詳細
フォーマット:	Online
言語:	英語
出版事項:	MDPI - Multidisciplinary Digital Publishing Institute 2022
主題:	NAFLD mouse models multifactorial disease translational value non-alcoholic fatty liver disease steatohepatitis NASH cognitive impairment memory dysfunction Alzheimer’s disease neurodegeneration liver stiffness liver steatosis controlled attenuation parameter transient elastography MRI PDFF MR spectroscopy non-alcoholic steatohepatitis (NASH) tunneling nanotubes (TNTs) primary hepatocytes organelle transfer mesenchymal stromal cells aminopyrine microsomal liver function breath test nonalcoholic fatty liver disease nonalcoholic steatohepatitis extracellular vesicles magnesium (Mg2+) obesity insulin resistance (IR) type 2 diabetes mellitus (T2DM) hypertension cardiovascular diseases (CVD) non-alcoholic steatohepatitis intestinal permeability microbiota probiotics physical exercise fecal microbiota transplantation hepatocellular carcinoma pathogenesis extra-hepatic outcome organ-on-a-chip artificial intelligence liver disease GLP-1 agonist SGLT-2 inhibitor type 2 diabetes innate immune system adaptive immune system metabolic syndrome fatty liver leptin n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
オンライン･アクセス:	ONIX_20220224_9783036529790_116
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

このレコードへの初めてのコメントを付けませんか!

NASH and Systemic Complications

類似資料